Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$224.73 - $338.64 $471,933 - $711,144
-2,100 Reduced 16.82%
10,385 $2.57 Million
Q1 2022

May 13, 2022

BUY
$277.25 - $366.29 $83,175 - $109,887
300 Added 2.46%
12,485 $4.14 Million
Q4 2021

Feb 15, 2022

BUY
$300.63 - $371.35 $60,126 - $74,270
200 Added 1.67%
12,185 $4.38 Million
Q3 2021

Nov 15, 2021

SELL
$310.19 - $376.2 $589,361 - $714,780
-1,900 Reduced 13.68%
11,985 $3.9 Million
Q2 2021

Aug 12, 2021

SELL
$262.71 - $351.17 $315,252 - $421,404
-1,200 Reduced 7.95%
13,885 $4.33 Million
Q1 2021

May 17, 2021

BUY
$285.92 - $355.13 $314,512 - $390,643
1,100 Added 7.87%
15,085 $4.81 Million
Q4 2020

Feb 12, 2021

SELL
$251.88 - $324.2 $75,564 - $97,260
-300 Reduced 2.1%
13,985 $4.53 Million
Q3 2020

Nov 13, 2020

BUY
$255.22 - $317.0 $306,264 - $380,400
1,200 Added 9.17%
14,285 $3.96 Million
Q2 2020

Aug 13, 2020

SELL
$141.4 - $257.09 $56,560 - $102,835
-400 Reduced 2.97%
13,085 $3.16 Million
Q1 2020

May 11, 2020

BUY
$130.51 - $196.01 $78,306 - $117,606
600 Added 4.66%
13,485 $1.96 Million
Q4 2019

Feb 10, 2020

BUY
$159.31 - $223.54 $509,792 - $715,328
3,200 Added 33.04%
12,885 $2.2 Million
Q3 2019

Oct 31, 2019

SELL
$175.89 - $279.23 $223,732 - $355,180
-1,272 Reduced 11.61%
9,685 $1.72 Million
Q2 2019

Jul 17, 2019

SELL
$250.96 - $284.94 $351,344 - $398,916
-1,400 Reduced 11.33%
10,957 $2.85 Million
Q1 2019

Apr 29, 2019

BUY
$276.39 - $362.25 $695,397 - $911,421
2,516 Added 25.57%
12,357 $3.53 Million
Q4 2018

Jan 31, 2019

SELL
$281.08 - $444.25 $534,052 - $844,075
-1,900 Reduced 16.18%
9,841 $3.2 Million
Q3 2018

Nov 09, 2018

SELL
$354.53 - $449.75 $70,906 - $89,950
-200 Reduced 1.67%
11,741 $5.28 Million
Q2 2018

Jul 12, 2018

BUY
$278.07 - $446.21 $3.32 Million - $5.33 Million
11,941 New
11,941 $4.88 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Fjarde Ap Fonden Portfolio

Follow Fjarde Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.